Introduction: This literature survey aims to extend the comprehensive survey performed by
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …

Drug treatments available for the management of substance use disorders (SUD) present
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …

Metabolic and behavioural effects of, and interactions between Δ9-tetrahydrocannabinol
(THC) and cannabidiol (CBD) are influenced by dose and administration route. Therefore …

Recent evidence suggests that cannabidiol (CBD) may be useful for the treatment of
different neuropsychiatric disorders. However, some controversy regarding its profile as a …

Background: Schizophrenia is a serious mental illness that affects more than 21 million
people worldwide. Both genetics and the environment play a role in its etiology and …

Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental
disorders that cause high levels of functional disabilities. Also, the currently available …

Background and Purpose The aim of this study was to explore if the administration of
naltrexone together with cannabidiol (CBD) may improve the efficacy in reducing alcohol …

Early life stress (ELS) is associated with the later development of schizophrenia. In the
rodent model, the maternal separation (MS) stress may induce neuronal apoptosis and …

AKB48 is a designer drug belonging to the indazole synthetic cannabinoids class, illegally
sold as herbal blend, incense, or research chemicals for their psychoactive cannabis-like …

Schizophrenia presents a complex mental health challenge, often inadequately addressed
by existing antipsychotic treatments, leading to persistent symptoms and adverse effects …